Monitor your energy levels and weight to avoid underfueling, and coordinate closely with your prescribing provider. During the first few weeks after switching: You might experience some mild digestive symptoms again, similar to when you first started semaglutide Your healthcare provider may want to monitor your blood sugar more closely if you have diabetes Your weight loss may temporarily slow as your body adjusts to the new medication Just like when you started semaglutide, you'll gradually increase your tirzepatide dose over several months until you reach the target maintenance dose that works best for you
ESSENCE is testing the effects of once-weekly subcutaneous injections of semaglutide (2.4 mg) against a placebo in about 1,200 adults with MASH and moderate to advanced liver fibrosis
For instance, the data from large clinical trials in type 2 diabetes show that GLP-1s and SGLT-2s not only lower glucose but also protect the heart and kidneys
The researchers administered 2.4 mg subcutaneous semaglutide (Wegovy, Novo Nordisk) once weekly to patients with obesity and moderate knee OA, who had at least moderate pain, and compared their outcomes with a placebo group over 68 weeks
Check your insurance coverage The first step is to see if your health plan covers Ozempic